Stay updated on TAS-102 vs Placebo in Metastatic Gastric Cancer Clinical Trial

Sign up to get notified when there's something new on the TAS-102 vs Placebo in Metastatic Gastric Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the TAS-102 vs Placebo in Metastatic Gastric Cancer Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The Publications section now states that entries are automatically filled from PubMed with Revision: v3.3.1, replacing the previous wording about PubMed-generated lists (Revision: v3.2.0).
    Difference
    0.0%
    Check dated 2025-11-21T01:53:35.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The government funding notice warning was removed from the page. This note previously warned that information might not be up to date and inquiries could be delayed during funding lapses.
    Difference
    0.2%
    Check dated 2025-11-13T22:28:12.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    The screenshots indicate only minor UI/layout refinements with no changes to core study content, such as objectives, eligibility, endpoints, or results. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-10-30T13:12:28.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    Core content updated with an operating-status notice and a version upgrade from v3.0.2 to v3.2.0.
    Difference
    2%
    Check dated 2025-10-02T01:22:09.000Z thumbnail image
  6. Check
    57 days ago
    Change Detected
    Summary
    Update: version revision changed from v3.0.2 to v3.1.0.
    Difference
    0.0%
    Check dated 2025-09-30T13:16:05.000Z thumbnail image
  7. Check
    64 days ago
    Change Detected
    Summary
    Core content on drug safety and related topics has been removed, reducing important information about drug safety, counterfeit drugs, pharmaceutical preparations, and substandard drugs.
    Difference
    0.2%
    Check dated 2025-09-23T09:46:52.000Z thumbnail image

Stay in the know with updates to TAS-102 vs Placebo in Metastatic Gastric Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the TAS-102 vs Placebo in Metastatic Gastric Cancer Clinical Trial page.